Sources inform “Globes” that AstraZeneca plc (NYSE; LSE; OMX: AZN) has teamed with Israeli real estate company Minrav Holdings Ltd. (TASE: MNRV) to bid in the Office of the Chief Scientist’s biotechnology incubator tender. AstraZeneca will handle the consortium’s professional side, and Minrav will be responsible for financing.
The AstraZeneca-Minrav consortium is bidding against a consortium of OrbiMed Israel and the venture capital arms of Johnson & Johnson (NYSE: JNJ) and Japan’s Takeda Pharmaceuticals Co. Ltd. (TSE: 4502).
To read the full, original article click on this link: Sources say AstraZeneca, Minrav formed consortium to bid in biotech incubator tender | MedCity News
{iframe}http://medcitynews.com/2013/07/sources-say-astrazeneca-minrav-formed-consortium-to-bid-in-biotech-incubator-tender/?utm_source=MedCity+News+Subscribers&utm_campaign=4e85b73a38-RSS_Daily+Top+Stories&utm_medium=email&utm_term=0_c05cce483a-4e85b73a38-67016725{/iframe}